Navigation Links
ZINO Society's Call for Life Sciences Entrepreneurs Seeking Funding

SEATTLE, Dec. 8 /PRNewswire/ -- ZINO Society is pleased to present ZINO Life: Life Sciences Investment Forum in partnership with the Washington Biotechnology and Biomedical Association (WBBA), on February 24, 2009.

ZINO Life will include exhibition space, networking, company presentations, keynote speaker Bruce Montgomery (Gilead Sciences), and an expert panel including H. Stewart Parker (formerly Targeted Genetics), Wayne Embree (Reference Capital Management LLC), Alan Smith (Fenwick & West LLP) and others. The day culminates with a wine reception and People's Choice Awards for presenters. In addition, one of the 12 companies will be invited to present at WBBA's Invest Northwest conference, March 17th - 18th 2009.

Reference Capital will select the best investment opportunity as determined by Reference Capital Management LLC and a $50,000 fund will be awarded in early 2009. "We see excellent opportunities within the Life Sciences in the region and we want to capitalize on them," said Founder and Managing Director of Reference Capital, Wayne Embree.

Selection Process:

Twelve early stage or expansion companies in the areas of life sciences, biotechnology, medical devices, diagnostics, and health-care information technology looking for start up or expansion capital. Companies will be selected to present their business plans to angel investors and business leaders.

Companies who would like to be considered to present at ZINO Life need to submit an online application, upload an executive summary that is no more than 5 pages long, and pay a $150 application fee.

The ZINO Society screening board will select a group of semi-finalists to move forward to a second level screening round. Those companies will be asked to present to the ZINO Society screening/coaching board on January 22 or 23, 2009. From these finalists, 12 companies will be selected to present their businesses at ZINO Life on February 24, 2009. The companies selected to present will participate in two coaching sessions prior to the forum, included in the presentation fee. The goal of the coaching sessions is to help each presenter be as effective as possible during his/her presentation to the investors.

    Facts Sheet:

    Application deadline:              January 13, 2009, by 5:00 PM
    Application site:       
    Application fee:                   $150 first-time applicants, $100
                                        returning applicants
    Presentation format:               5 minutes presentation 2 minutes for
                                        Q & A.
    Presentation fee:                  $850
    Semi-finalists notified:           January 20, 2009
    Semi-finalists present to
     ZINO Life screening committee:    January 22 or 23, 2009 (Please reserve
                                        these dates)
    Presenters announced:              January 26, 2009
    Coaching meetings:                 February 2 - February 20, 2009
    ZINO Life: Life Sciences
     Investment Forum                  February 24, 2009 2:00 PM - 6:00 PM

About ZINO Society

ZINO Society is a premier membership, business and social network that connects accredited investors with entrepreneurs seeking funding. Since its conception, ZINO Society has helped facilitate in excess of $9.1 million for early-stage and expansion businesses.

About The Washington Biotechnology & Biomedical Association (WBBA)

The Washington Biotechnology & Biomedical Association is a not-for-profit association of more than 450 life sciences companies, universities, academic institutions and others working together to provide better health to people everywhere.

Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. The Pharma & Life Sciences Best Practice Database: an Industry Resource for Successful Techniques and Performance Benchmarks for Reaching the Top
2. Edwards Lifesciences to Present at the Bear Stearns 20th Annual Healthcare Conference
3. Edwards Lifesciences Receives CE Mark for Edwards SAPIEN Transcatheter Heart Valve
4. Sangamo BioSciences to Present at the ThinkEquity Partners Growth Conference
5. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
6. Novavax CEO to Present at the 2007 UBS Global Life Sciences Conference
7. Cardiac Science to Present at the UBS Global Life Sciences Conference
8. Akers Biosciences, Inc. ABI or the Company Receipt of Further United States Military Contracts
9. DRAXIS to Present at the 2007 UBS Global Life Sciences Conference
10. ViroPharma to Present at the UBS Global Life Sciences Conference
11. Clarient to Present at the UBS 2007 Global Life Sciences Conference
Post Your Comments:
(Date:12/1/2015)... ... 2015 , ... The Multiple System Atrophy Coalition has announced the launch of ... (MSA) research, timed today to coincide with Giving Tuesday 2015, a global day of ... to work and be productive, to do simple daily activities like walking to the ...
(Date:12/1/2015)... ME (PRWEB) , ... December 01, 2015 , ... Royal ... reports a new study that found post-menopausal women who took the nutritional supplement creatine, ... than women who trained but did not take creatine. , The report is part ...
(Date:12/1/2015)... Fla. (PRWEB) , ... December 01, 2015 , ... ... number of leadless pacemakers in the U.S. and is the only hospital in ... from the largest clinical data presentation of transcatheter pacing patients were revealed recently ...
(Date:12/1/2015)... ... December 01, 2015 , ... December 1, ... expansion of the company’s growing product line of food safety and seafood fraud ... Sockeye (Oncorhynchus nerka) – allow InstantLabs to offer fast, reliable species identification for ...
(Date:12/1/2015)... ... December 01, 2015 , ... Diabetic ... United States. Podiatrists are well aware that psychology-based patient non-compliance (disobedience of a ... catastrophic contributors to diseases of the diabetic foot. The American Board of ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... 1, 2015   MabVax Therapeutics Holdings, Inc . ... it has filed an Investigational New Drug Application (IND) ... the Company,s lead fully human antibody product HuMab 5B1 ... plans to initiate the Phase I clinical trial early ... --> The planned Phase I trial will evaluate ...
(Date:12/1/2015)... , Dec. 1, 2015   Craneware, Inc ... cycle solutions, today announced the company will showcase ... ChargeLink ® solution at the American ... Clinical Meeting . The new features are focused ... of monitoring and managing enterprise-wide pharmacy charges to ...
(Date:12/1/2015)... , Dec. 01, 2015 ... of the "Medical Alert Systems/Personal Emergency Response ... by Geography - Global Forecas" report to ... announced the addition of the "Medical Alert ... by End-User and by Geography - Global Forecas" ...
Breaking Medicine Technology: